Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00146068Phase 4Completed
Phase 4, randomised, double-blind trial in clinically isolated syndrome (CIS) comparing Avonex + Zocor with Avonex + Placebo (2 arms). Primary endpoints: Relapse Rate at 1 year, Time to First Relapse at 1 year and 2 more. Started Sep 2004; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00146068.